Substance Use Disorders and Their Correlates Among Inmates in a Sri Lankan Prison

Author(s):  
Aruni Hapangama ◽  
G.B.M.S Dasanayake ◽  
K A L A Kuruppuarachchi ◽  
A Pathmeswaran ◽  
H de Silva

Abstract IntroductionSubstance abuse and dependence are common among prison populations. However, there is few data regarding this problem in Sri Lankan. Objective: To determine the prevalence of substance use disorders among inmates in a Sri Lankan prisonMethod: A semi- structured interviewer administered questionnaire and ICD 10 clinical diagnostic criteria were applied to 410 randomly selected male and female prisoners in minimum/medium security settings in the largest prison in Sri Lanka.Results: 75.6% (95% CI 71.2 – 79.5) of prisoners had lifetime substance use disorder while 24.4% (95% CI 20.2– 28.6) met criteria for current substance use disorder. 56.8% and 67 % of participants met criteria for lifetime alcohol and tobacco use disorders, respectively, while and 42 %and 25.6% had lifetime cannabis and opioid dependence, respectively. Factors significantly associated with lifetime substance use disorder were male gender, residence in an urban area, younger age and being unemployed or having only temporary employment. 23% of participants who met criteria for dependence were intravenous substance users.Conclusions: Services should be improved in the prison health system to minimize harm from substance use disorders.

Author(s):  
Philip Cowen ◽  
Paul Harrison ◽  
Tom Burns

The phrases substance use disorder (DSM-IV) or disorders due to psychoactive drug use (ICD-10) are used to refer to conditions arising from the misuse of alcohol, psychoactive drugs, or other chemicals such as volatile substances. In this chapter, problems related to alcohol will be discussed first under the general heading of alcohol use disorders. Problems related to drugs and other chemicals will then be discussed under the general heading of other substance use disorders.


2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.


2019 ◽  
Vol 1 (3) ◽  
pp. 1-15 ◽  
Author(s):  
Austin M Brown ◽  
Robert D Ashford

As recovery from substance use disorder becomes more than a mere quantifiable outcome, there exists a need to discuss and propose the underlying theoretical constructs that ultimately describe and identify the science of recovery. In this abstract undertaking, we propose an initial formulation of a grand theory of recovery science, built upon the seminal theories of recovery capital, recovery-oriented systems of care, and socioecological theory. This grand theory - labeled recovery-informed theory (RIT) - states that successful long-term recovery is self-evident and is a fundamentally emancipatory set of processes. This paper will discuss, analyze, and explore this theory as it is situated within the larger substance use, misuse, and disorder contexts. The uses, implications, and benefits of RIT as an organizing point of inquiry for recovery science are also discussed. By promoting the role of subjective recovery experience in the formulation of the study of recovery, it may be possible to summon new ideas, metrics, and strategies that can directly address substance use disorders in society. Adopting a recovery-informed understanding as follows from this grand theory may allow individual recovery and wellness trajectories to be explored, adapted, and modified to exemplify person-centered and individualized recovery strategies.


Author(s):  
Sudie E. Back ◽  
Edna B. Foa ◽  
Therese K. Killeen ◽  
Katherine L. Mills ◽  
Maree Teesson ◽  
...  

This chapter provides the therapist with an outline of the COPE treatment and components of each session (e.g. check-in, review homework, post-traumatic stress disorder [PTSD] focus, substance use disorder focus). Questions regarding who can deliver the therapy are addressed, as well as questions regarding the role of medications. Finally, special considerations for delivering treatment to patients with PTSD and comorbid substance use disorders are reviewed for the therapist.


Author(s):  
Dennis C. Daley ◽  
Antoine Douaihy

Substance use can contribute directly and indirectly to problems in any area of life. Substance use disorders raise the risk of medical, spiritual, psychological, psychiatric, family, and economic problems. Problems may range in severity from mild to life-threatening. Sometimes the effects are subtle or hidden. The goals of this chapter are for the client to understand the consequences of their substance use and its effect on the people closest to them and to identify problems caused by the client’s substance use disorder.


Author(s):  
Dennis C. Daley ◽  
Antoine Douaihy

The American Psychiatric Association classifies substance-related disorders into several categories. These include intoxication, withdrawal, substance use disorder, and substance-induced disorder. The goals of this chapter are to understand the different categories and symptoms of substance use disorders and to rate the overall severity of the client’s substance use problem.


2020 ◽  
Vol 63 (1) ◽  
Author(s):  
Thomas Fovet ◽  
Laurent Plancke ◽  
Alina Amariei ◽  
Imane Benradia ◽  
Fanny Carton ◽  
...  

Abstract Background. The aim of the present study was to estimate prevalence rates of psychiatric and substance use disorders in male and female prisoners on admission to prison in the north of France and compare the frequency of these disorders to the general population. Methods. This cross-sectional survey on Mental Health in the Prison Population (MHPP), conducted between March 2014 and April 2017, interviewed 653 randomly selected men and women who had recently been committed to the French general population prison system in the Nord and Pas-de-Calais departments. For each subject, the Mini International Neuropsychiatric Interview (MINI), a standardized psychiatric interview, was used to screen for psychiatric and substance use disorders. The prevalence rates were then compared with data from the Mental Health in the General Population (MHGP) survey, a general population survey that used the same assessment methodology as MHPP in the Nord and Pas-de-Calais departments. A control sample was taken from the MHGP survey with a ratio of one case (MHPP) to three controls (MHGP) matching on age and sex. Results. The sample was primarily composed of French men, most of them single with low educational levels at the time of imprisonment. The mean age was 31.7 (standard deviation = 9.9; min = 18; max = 67). Most of the subjects included were first-time prisoners. The prevalence of affective disorders among newly incarcerated individuals was 31.2% with higher rates for major depressive disorder (27.2%). The prevalence of anxiety disorders was 44.4% with higher rates for generalized anxiety disorder (25.2%). The prevalence of psychotic syndromes was 6.9%. The prevalence of substance use disorders was 53.5% and a suicide risk was identified in 31.4% of the prisoners interviewed. Higher prevalence rates were found in the MHPP when compared with the MHGP for all psychiatric and substance use disorders assessed except for dysthymia and current isolated psychotic syndrome. Conclusions. Our study shows very high levels of prevalence for psychiatric and substance use disorders in recently committed French prisoners.


Author(s):  
Patrece Hairston ◽  
Ingrid A. Binswanger

The nexus of substance use disorders and criminal justice involvement is considerable. This is particularly the case in the United States, where 48% of individuals in federal prisons were incarcerated for drug-related convictions in 2011. In the last year for which national data are available, approximately half of the individuals incarcerated in state and federal prisons met criteria for drug abuse or dependence. Tobacco and alcohol use are also more common in correctional populations than in the general, non-institutionalized population. Thus, criminal justice populations have a significant need for evidence-based treatment of addiction and interventions to reduce the medical complications of drug use. While many programs to address substance use disorder among correctional populations exist, many individuals fail to receive adequate care and continue to experience complications of substance use disorders. Thus, correctional clinicians and staff, researchers, and patients will need to continue to advocate for improved and enhanced dissemination of integrated, evidence-based behavioral and pharmacological treatment for substance use disorder across the continuum of criminal justice involvement. This chapter describes the evolution of addiction programming within correctional settings from the late 1700s to contemporary practices. Beginning with a discussion of mutual aid societies as one of the earliest providers of ‘treatment,’ this chapter outlines important aspects of early treatment. Additionally, current levels of care and specialized modalities for individuals involved in the criminal justice system are presented, such as cognitive-behavioral interventions, drug courts, therapeutic communities, pharmacologically supported therapy, and harm reduction approaches.


Sign in / Sign up

Export Citation Format

Share Document